Order Article Reprints

Inomata M, Azechi K, Takata N, Hayashi K, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, et al. Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy. Diagnostics. 2020; 10(12):1006. https://doi.org/10.3390/diagnostics10121006

Inomata, Minehiko, Kenji Azechi, Naoki Takata, Kana Hayashi, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Toshiro Miwa, and et al. 2020. "Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy" Diagnostics 10, no. 12: 1006. https://doi.org/10.3390/diagnostics10121006

Inomata, M., Azechi, K., Takata, N., Hayashi, K., Tokui, K., Taka, C., Okazawa, S., Kambara, K., Imanishi, S., Miwa, T., Hayashi, R., Matsui, S., & Tobe, K. (2020). Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy. Diagnostics, 10(12), 1006. https://doi.org/10.3390/diagnostics10121006